Key terms

About VNDA

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest VNDA news

Yesterday 11:21am ET Vanda Pharmaceuticals up 16% after disclosing receipt of revised Future Pak bid by TipRanks Yesterday 11:19am ET Vanda confirms receipt of revised takeover bid from Future Pak by TipRanks Apr 25 8:11am ET Shareholder Capital delivers letter to board of Vanda Pharmaceuticals by TipRanks Apr 22 7:15pm ET Vanda Pharmaceuticals responds to U.S. Supreme Court denial of petition by TipRanks Apr 19 11:12am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Apr 17 10:25am ET Vanda adopts limited duration stockholder rights plan by TipRanks Apr 17 9:05am ET Vanda rejects unsolicited acquisition proposal from Future Pak by TipRanks Apr 17 6:32am ET Future Pak confirms proposal to acquire Vanda Pharmaceuticals for $7.25-$7.75 by TipRanks Apr 05 10:40am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Apr 03 8:17am ET Vanda (NASDAQ:VNDA) Soars After U.S. FDA Greenlights Fanapt for Bipolar Disorder by TipRanks Apr 02 6:10pm ET Vanda Pharmaceuticals’ Fanapt receives FDA approval by TipRanks Mar 06 7:05am ET Vanda Pharmaceuticals receives CRL from FDA regarding sNDA for HETLIOZ by TipRanks Feb 21 4:44pm ET Vanda Pharmaceuticals Sets New Executive Compensation Packages by TipRanks
Mar 29 11:24am ET SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceutical Inc. - VNDA by Newsfile Mar 21 1:37pm ET SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceutical Inc. - VNDA by Newsfile Mar 13 9:47am ET SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceutical Inc. - VNDA by Newsfile

VNDA Financials

1-year income & revenue

Key terms

VNDA Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

VNDA Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Scaffolding and construction netting near an apartment building in New York, US, on Wednesday, Oct. 11, 2023. Monthly fees and expenses for inspections, insurance and climate-friendly upgrades are squeezing residents of the city's many co-op and condo buildings. Photographer: Michael Nagle/Bloomberg
Michael Nagle/Bloomberg/Getty Images
For US renters, the chance of owning a home is going from bad to worse
Close-up detail of the Disney+ app icon on an Apple iPhone 12 Pro smartphone screen, on November 11, 2020. (Photo by Phil Barker/Future Publishing via Getty Images)
Phil Barker/Future Publishing/Getty Images
Disney just had its worst day in a year and a half
People shop in a supermarket in the Manhattan borough of New York city on January 27, 2024. (Photo by Charly TRIBALLEAU / AFP) (Photo by CHARLY TRIBALLEAU/AFP via Getty Images)
Charly Triballeau/AFP/Getty Images
Americans have spent their savings. Economists worry about what comes next
Berkshire Hathaway Chairman Warren Buffett walks through the exhibit hall as shareholders gather to hear from the billionaire investor at Berkshire Hathaway Inc's annual shareholder meeting in Omaha, Nebraska, on May 4, 2019.
Scott Morgan/Reuters/File
Warren Buffett compares AI to nuclear weapons in stark warning